Reclipsen
Product Images NDC 53002-1631

6 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Reclipsen (NDC 53002-1631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula 1 (Image 1)

Structural Formula 1 (Image 1)
Chemical structure of the active ingredient in Reclipsen 28 Day by RPK Pharmaceuticals, Inc., showing a steroid backbone with hydroxyl and alkyne functional groups present.*
FDA Label Image

Structural Formula 2 (Image 2)

Structural Formula 2 (Image 2)
Chemical structure diagram showing a steroid backbone with hydroxy and acetylene functional groups, consistent with the structure of the active ingredient in Reclipsen 28 Day by RPK Pharmaceuticals, Inc.*
FDA Label Image

Table I (Image 3)

Table I (Image 3)
A bar chart showing mortality rates (number of deaths per 100,000 woman-years) across four age groups (15-24, 25-34, 35-44, 45- ) for four categories: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers). Rates increase with age and vary by smoking status and ever-use.*
FDA Label Image

Figure 2 (Image 4)

Figure 2 (Image 4)
A forest plot chart titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' displaying effect estimates (OR/RR) from various studies. It lists eight studies from 2002 to 2017, showing odds ratios with confidence intervals on a scale from -1.5 to 2, centered around 1. The plot distinguishes between ever use and current use, with most estimates close to 1, indicating no strong association.*
FDA Label Image

Blister (Image 5)

Blister (Image 5)
Reclipsen 28 Day oral contraceptive tablet pack by RPK Pharmaceuticals, Inc. The blister pack contains 28 round tablets arranged in a 4-week calendar format with days labeled Sunday through Saturday. The first 21 tablets are light gray, and the last 7 tablets are white. The active ingredients are desogestrel 0.15 mg and ethinyl estradiol 0.03 mg, as indicated on the pack.*
FDA Label Image

Label Image (Lbl530021631)

Label Image (Lbl530021631)
Reclipsen 28 Day, 0.15/0.03 mg tablets, 28-count blister card packaging label by RPK Pharmaceuticals, Inc. The label indicates a 28-day regimen with daily dosing instructions to take one tablet daily as directed. It includes lot number, expiration date, patient name, barcode, and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.